Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Subject index<br />
A<br />
Acantholytic variant, squamous cell <strong>carcinoma</strong>,<br />
38, 40, 41<br />
Acanthosis nigricans, 189<br />
Acinic cell <strong>carcinoma</strong>, 45<br />
Acquired melanocytic naevus, 331, 332<br />
Adeno<strong>carcinoma</strong> in situ, 232, 272, 273,<br />
275, 276<br />
Adeno<strong>carcinoma</strong> of Skene gland origin,<br />
324<br />
Adeno<strong>carcinoma</strong> of the rete ovarii, 180<br />
Adeno<strong>carcinoma</strong> with spindle cell metaplasia,<br />
38<br />
Adenocystic basal cell <strong>carcinoma</strong>, 44<br />
Adenofibroma, 122, 124, 125, 127, 130,<br />
196, 209, 245, 248, 284, 285<br />
Adenohibernoma, 103<br />
Adenoid basal <strong>carcinoma</strong>, 267, 277-<br />
279, 301<br />
Adenoid cystic <strong>carcinoma</strong>, 28, 44, 57,<br />
86, 182, 184, 185, 228, 267, 277-<br />
279, 301, 321-323<br />
Adenolipoma, 94, 103<br />
Adenoma malignum, 273<br />
Adenoma of minor vestibular glands,<br />
324<br />
Adenoma of the rete ovarii, 181<br />
Adenomatoid tumour, 197, 199, 211,<br />
243, 244, 310<br />
Adenomatous hyperplasia of the rete<br />
ovarii, 181<br />
Adenomyoepithelial adenosis, 82, 86, 87<br />
Adenomyoepithelioma, 44, 46, 82, 86, 87<br />
Adenomyoma, 134, 188, 215, 235, 245,<br />
249, 273, 284-286, 321, 323<br />
Adenosarcoma, 130, 133, 210, 212,<br />
215, 244-248, 281, 282, 284-286,<br />
306, 307<br />
Adenosis, 78, 81-83, 85, 87, 104, 295,<br />
297, 299, 300<br />
Adenosis with apocrine metaplasia, 82<br />
Adenosquamous <strong>carcinoma</strong>, 39-41,<br />
130, 174, 266, 273, 277, 278, 301,<br />
321, 322<br />
A d re n o c o rtical <strong>carcinoma</strong>, 351, 352, 354<br />
Adult granulosa cell tumour, 131, 146<br />
AFP, see alpha-fetoprotein<br />
Aggressive angiomyxoma, 305, 329<br />
Aggressive T-cell leukaemia, 361<br />
Akt, 231, 357<br />
Alpha lactalbumin, 41, 43<br />
Alpha-fetoprotein, 138, 155, 156, 165-<br />
168, 184, 207, 246, 309<br />
Alveolar rhabdomyosarcoma, 215, 244,<br />
282<br />
Alveolar soft part sarcoma, 215, 244,<br />
280-282, 304, 326, 327<br />
Alveolar variant, lobular <strong>carcinoma</strong>, 24, 32<br />
Amenorrhea, 154, 157, 175, 190<br />
Amylase, 45<br />
Androblastoma, 153<br />
Androgen insensitivity syndrome, 157<br />
Androgen receptor gene, 112, 154<br />
Angiogenesis, 22<br />
Angiolipoma, 93<br />
Angiomyofibroblastoma, 327, 329, 330<br />
Angiosarcoma, 40, 89, 91, 94-96, 175,<br />
188, 244, 280, 282, 304<br />
Apocrine adenoma, 85<br />
Apocrine adenosis, 82<br />
Apocrine <strong>carcinoma</strong>, 36, 37, 47, 71<br />
Apocrine cell, 36, 37, 47, 65<br />
APPBP2, 51<br />
Argyrophilia, 33, 80<br />
A-T complementation, 361<br />
Ataxia telangiectasia, ,27, 342, 350,<br />
353, 361-363<br />
ATM see Ataxia telangiectasia<br />
Atypical adenosis, 299, 300<br />
Atypical carcinoid, 277, 279<br />
Atypical columnar change, 66<br />
Atypical cystic lobules, 63, 66<br />
Atypical ductal hyperplasia, 20, 63, 64,<br />
66, 78<br />
Atypical hyperplasia, 63, 84, 136, 210,<br />
221, 222, 228, 229, 232, 359<br />
Atypical intraductal hyperplasia, 66, 78<br />
Atypical leiomyoma, 236, 241<br />
Atypical lobular hyperplasia, 60<br />
Atypical lobules, type A, 66<br />
Atypical medullary <strong>carcinoma</strong>, 28, 338<br />
Atypical melanocytic naevus of the genital<br />
type, 332<br />
Atypical papilloma, 78<br />
Atypical polypoid adenomyoma, 249,<br />
285, 286<br />
Atypical proliferative serous tumour, 121<br />
Atypical vulvar naevus, 332<br />
Aurora-A, 51<br />
B<br />
B72.3 (TAG-72) antibody, 119, 131, 138,<br />
187<br />
Bannayan-Riley-Ruvalcaba syndrome,<br />
357<br />
BARD1, 342<br />
Barr bodies, 171<br />
Bartholin gland adenoma, 323<br />
Bartholin gland <strong>carcinoma</strong>, 322<br />
Bartholin gland nodular hyperplasia,<br />
323<br />
Bartholin gland tumour, 321, 322<br />
Basal cell <strong>carcinoma</strong>, 151, 174, 175,<br />
184, 185, 316, 318, 319<br />
Basal cell tumour, 182, 184, 185<br />
Basaloid <strong>carcinoma</strong>, 267, 316<br />
Basaloid squamous cell <strong>carcinoma</strong>, 267,<br />
278, 279, 317<br />
BASC, see BRCA1-associated surveillance<br />
complex<br />
Bcl-2, 58, 92, 108, 109, 250<br />
BEK, 51<br />
Benign mesothelioma, 199<br />
Benign metastasizing leiomyoma, 237,<br />
242<br />
Benign mixed epithelial tumour, 144<br />
Benign mixed tumour, 85, 306, 307<br />
Benign peripheral nerve sheath tumour,<br />
92, 94<br />
Benign sclerosing ductal proliferation, 83<br />
Beta-catenin, 131<br />
Bethesda Criteria, 358<br />
ß-hCG, 22, 164, 165, 167, 168, 207,<br />
250, 251, 252<br />
Bilateral <strong>breast</strong> <strong>carcinoma</strong>, 23, 48<br />
Subject Index 425